Patterns of symptom development in patients with motor neuron disease
Walhout, Renée; Verstraete, Esther; Van Den Heuvel, Martijn P; Veldink, Jan H; Van Den Berg, Leonard H
(2018) Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, volume 19, issue 1-2, pp. 21 - 28
(Article)
Abstract
Objective: To investigate whether symptom development in motor neuron disease (MND) is a random or organized process. Methods: Six hundred patients with amyotrophic lateral sclerosis (ALS), upper motor neuron (UMN) or lower motor neuron (LMN) phenotypes were invited for a questionnaire concerning symptom development. A binomial test was used to
... read more
examine distribution of symptoms from site of onset. Development of symptoms over time was evaluated by Kaplan-Meier analysis. Results: There were 470 respondents (ALS = 254; LMN = 100; UMN = 116). Subsequent symptoms were more often in the contralateral limb following unilateral limb onset (ALS: arms p = 1.05 × 10 −8 , legs p < 2.86 × 10 −15 ; LMN phenotype: arms p = 6.74 × 10 −9 , legs p = 6.26 × 10 −6 ; UMN phenotype: legs p = 4.07 × 10 −14 ). In patients with limb onset, symptoms occurred significantly faster in the contralateral limb, followed by the other limbs and lastly by the bulbar region. Patterns of non-contiguous symptom development were also reported: leg symptoms followed bulbar onset in 30%, and bulbar symptoms followed leg onset in 11% of ALS patients. Conclusions: Preferred spread of symptoms from one limb to the contralateral limb, and to adjacent sites appears to be a characteristic of MND phenotypes, suggesting that symptom spread is organized, possibly involving axonal connectivity. Non-contiguous symptom development, however, is not uncommon, and may involve other factors.
show less
Download/Full Text
Keywords: upper motor neuron, lower motor neuron, symptom development, Motor neuron disease, amyotrophic lateral sclerosis, Humans, Middle Aged, Kaplan-Meier Estimate, Male, Disease Progression, Young Adult, Phenotype, Aged, 80 and over, Motor Neurons/physiology, Adult, Female, Surveys and Questionnaires, Aged, Amyotrophic Lateral Sclerosis/diagnosis, Clinical Neurology, Neurology, Journal Article, Research Support, Non-U.S. Gov't
ISSN: 2167-8421
Publisher: Informa Healthcare
Note: Funding Information: R. Walhout reports no disclosures. E. Verstraete received a consultancy fee from Biogen Idec. MPvdH received a grant from The Netherlands Organization for Health Research and Development (Veni scheme), from the ALS Foundation Netherlands and from MQ. J.H. Veldink reports no disclosures. LHvdB received a grant from The Netherlands Organization for Health Research and Development (Vici scheme), travel grants and consultancy fees from Baxalta; serves on scientific advisory boards for Prinses Beatrix Spierfonds, Thierry Latran Foundation, Cytokinetics and Biogen. Funding Information: This study was supported by the ALS Foundation Netherlands, Prinses Beatrix Spierfonds, the European Community’s Health Seventh Framework Programme (grant agreement n° 259867), and the SOPHIA project (funded through the EU Joint Programme – Neurodegenerative Disease Research, JPND). Publisher Copyright: © 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
(Peer reviewed)